TAFFIC 30T

TAFFIC 30T About

Taffic Tablet contains Bictegravir 50mg, Emtricitabine 200mg and Tenofovir Alafenamide 25mg. This combination is an antiviral medicine combination used in the treatment of Human Immunodeficiency Virus (HIV) 1 infection. Bictegravir is an integrase strand transfer inhibitor. Emtricitabine and Tenofovir Alafenamide is a nucleoside reverse transcriptase inhibitor. It works by reducing the viral load of HIV in your body. This tablet combination improves your immune system and reduces the risk of conditions associated with HIV infection.

Effective BPH Symptom Relief

TAFFIC 30T is specifically designed to address urinary symptoms associated with benign prostatic hyperplasia (BPH) in adult men. Its dual-action formula helps to relax both bladder and prostate muscles, significantly improving urine flow and reducing discomfort. This therapeutic effect makes it a reliable option for those seeking relief from lower urinary tract symptoms.


Convenient Extended Release Formula

The tablet features an extended-release mechanism that ensures a steady release of the active ingredients throughout the day. This allows for once-daily dosing, enhancing adherence to the treatment plan. With each tablet, patients benefit from prolonged therapeutic efficacy and improved symptom management.


Safe Storage and Handling

To maintain the tablet's efficacy, TAFFIC 30T should be stored in a cool, dry, and dark place, protected from direct sunlight and moisture. Each container holds 30 tablets, ensuring a month's supply per pack when following the prescribed daily regimen.